Global private equity and venture capital transaction value totaled $35.28 billion in January, down slightly compared with ...

Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...

Bain said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare industry.

U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), ...

Private equity firm Bain Capital (BCSF) is paying $3.4 billion to buy a 350-year-old Japanese drugs group fighting diabetes ...

The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

The carve-out acquisition will allow Bain to capitalize on the “promising signs for growth” in the Japanese life sciences ...

Bain Capital kicked off the bidding war for MLC-owner Insignia Financial and has certainly pulled out all the stops to ...

Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...

Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...

Bain Capital Specialty Finance has shown strong performance with impressive earnings and solid portfolio quality. Read why I maintain my buy rating for BCSF.